Matrix
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Maule Stem Cell Research Institute, Inc.
Overview
Matrix is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Matrix clinical trials
Explore related
Medical disclaimer. This page summarizes research about Matrix for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.